Engineered Nanoplatforms Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy via TGF‐β Axis Inhibition and Ferroptosis Induction
- DOI
- 10.1002/adhm.71657
- Published
- 2026-09-11
- Container
- Advanced Healthcare Materials
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/adhm.71657,
title = {Engineered Nanoplatforms Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy via TGF‐β Axis Inhibition and Ferroptosis Induction},
author = {Yinuo Yang and Mengyao Mu and Ke Ren and Hui Liu and Pengju Ma and Yingqi Wang and Mengmeng Zhang and Xueli Xu and Wenzhe Li and Wenshuang Gao and Xiao Sun and Qiang Zhu},
year = {2026},
journal = {Advanced Healthcare Materials},
doi = {10.1002/adhm.71657},
url = {https://doi.org/10.1002/adhm.71657}
}RIS
TY - JOUR TI - Engineered Nanoplatforms Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy via TGF‐β Axis Inhibition and Ferroptosis Induction AU - Yinuo Yang AU - Mengyao Mu AU - Ke Ren AU - Hui Liu AU - Pengju Ma AU - Yingqi Wang AU - Mengmeng Zhang AU - Xueli Xu AU - Wenzhe Li AU - Wenshuang Gao AU - Xiao Sun AU - Qiang Zhu PY - 2026 JO - Advanced Healthcare Materials DO - 10.1002/adhm.71657 UR - https://doi.org/10.1002/adhm.71657 ER -
APA
Yang, Y., Mu, M., Ren, K., Liu, H., Ma, P., Wang, Y., Zhang, M., Xu, X., Li, W., Gao, W., Sun, X., & Zhu, Q. (2026). Engineered Nanoplatforms Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy via TGF‐β Axis Inhibition and Ferroptosis Induction. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71657
Source records
- crossref · retrieved 2026-09-25T07:32:00.571Z